Report cover image

mRNA: Therapeutics and Global Markets

Publisher BCC Research
Published Sep 10, 2025
Length 131 Pages
SKU # WA20408088

Description

Report Scope

The report analyzes the global market for mRNA therapeutics. It includes global revenue ($ millions) for the base year of 2024, estimated data for 2025 and projected compound annual growth rates (CAGRs) through 2030. The report examines the different types of mRNA and their applications for therapeutic use. It also focuses on mRNA patents and clinical trials and examines the trends affecting the market during the forecast period. The report profiles the leading companies and their strategic alliances and partnerships. The report segments the global market into North America, Europe, Asia-Pacific (APAC) and the Rest of the World (RoW).

Report Includes
  • 19 data tables and 71 additional tables
  • An overview and analysis of the global markets for messenger RNA (mRNA)-based therapeutics
  • Analyses of the global market trends, with revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
  • Estimates of the size and revenue prospects for the global mRNA market, along with a market share analysis by disease type, indication, and region
  • Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, regulations and the impacts of macroeconomic variables
  • Insights derived from Porter’s Five Forces model, global supply chain and PESTLE analyses
  • Patent analysis, featuring key granted and published patents
  • Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings and consumer attitudes
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Profiles of the leading companies, including Moderna Inc., Pfizer Inc., BioNTech SE, Merck & Co., and Sanofi


Companies Mentioned

Arcturus Therapeutics Inc.
Astrazeneca
Biocina
Biontech Se
Curevac Se
Ethris Gmbh
Gennova Biopharmaceuticals Ltd.
Gsk Plc.
Immorna (Hangzhou) Biotechnology Co. Ltd.
Merck & Co. Inc.
Moderna Inc.
Nutcracker Therapeutics Inc.
Pfizer Inc.
Providence Therapeutics
Sanofi
Strand Therapeutics Inc.

Table of Contents

131 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Growth Factors
Emerging Technologies
COVID mRNA Vaccines
Regional Analysis
Conclusion
Chapter 2 Market Overview
Technology Background
Evolution of RNA Therapeutics
DNA Therapeutics vs. RNA Therapeutics
RNA Therapeutics
mRNA as Therapeutics
Regulatory Agency-Approved mRNA Vaccines
Porter's Five Forces Analysis
Potential for New Entrants
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of Substitute Products or Services
Industry Competition
Impact of U.S. Tariffs on the mRNA Therapeutics Market
Conclusion
Chapter 3 Market Dynamics
Overview
Market Drivers
Rising Numbers of Pandemics and Epidemics
Awareness of the Need for Vaccinations
Investments in mRNA Therapeutics Research
Market Restraints
Limitations of mRNA Vaccines
Production and Logistical Hurdles
Market Opportunities
Personalized Cancer Vaccines
Potential of mRNA Drugs to Treat Various Diseases
Chapter 4 Regulatory Landscape
Regulatory Scenario
Overview of Regulatory Bodies
Guidelines and Standards for mRNA Vaccines
Preclinical and Clinical Evaluation
Manufacturing and Post-Marketing Surveillance
Continual Monitoring and Risk Management
Chapter 5 Pipeline and Clinical Trial Analysis
Takeaways
mRNA Vaccines
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Breakdown by Disease Type
Takeaways
COVID mRNA Vaccines
Non-COVID mRNA Vaccines and Therapeutics
Market Breakdown by Indication
Cancer
Infectious Diseases
Rare Diseases
Others
Geographic Breakdown
Market Breakdown, by Region
Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Emerging Technologies and Developments
Emerging Technologies in mRNA Therapeutics
Nanoparticles
Modified mRNA
Automated mRNA Synthesis Kits
Bio Platforms
Artificial Intelligence
AI Developments at mRNA Therapeutics Companies
Chapter 8 Patent Analysis
Takeaways
mRNA Publications
List of Patents
Chapter 9 Sustainability in the mRNA Therapeutics Industry: An ESG Perspective
Sustainability in the mRNA Therapeutics Industry
ESG Risk Ratings
ESG Performance Analysis
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC Research
Chapter 10 Competitive Intelligence
Takeaways
Leading Companies in the mRNA Therapeutics Market, 2024
Strategic Analysis
Collaborations and Partnerships
Regulatory Approvals
Clinical Trials Data
Funding and Grants
Chapter 11 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ARCTURUS THERAPEUTICS INC.
ASTRAZENECA
BIOCINA
BIONTECH SE
CUREVAC SE
ETHRIS GMBH
GENNOVA BIOPHARMACEUTICALS LTD.
GSK PLC.
IMMORNA (HANGZHOU) BIOTECHNOLOGY CO. LTD.
MERCK & CO. INC.
MODERNA INC.
NUTCRACKER THERAPEUTICS INC.
PFIZER INC.
PROVIDENCE THERAPEUTICS
SANOFI
STRAND THERAPEUTICS INC.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us